Related references
Note: Only part of the references are listed.FluBlok, a next generation influenza vaccine manufactured in insect cells
Manon M. J. Cox et al.
BIOLOGICALS (2009)
Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines)
Alexander Doroshenko et al.
EXPERT REVIEW OF VACCINES (2009)
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
P. Noel Barrett et al.
EXPERT REVIEW OF VACCINES (2009)
Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity
Keith S. Reisinger et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A Cell Culture (Vero)-Derived H5N1 Whole-Virus Vaccine Induces Cross-Reactive Memory Responses
Hartmut J. Ehrlich et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines
Diana Vester et al.
PROTEOMICS (2009)
Suitability of PER.C6® cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics
W. Koudstaal et al.
VACCINE (2009)
An avian cell line designed for production of highly attenuated viruses
Ingo Jordan et al.
VACCINE (2009)
Use of MDCK cells for production of live attenuated influenza vaccine
Jonathan Liu et al.
VACCINE (2009)
Glycan analysis in cell culture-based influenza vaccine production: Influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin
Jana Schwarzer et al.
VACCINE (2009)
Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling
J. Schulze-Horsel et al.
VACCINE (2009)
Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial
N. Groth et al.
VACCINE (2009)
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: Studies on growth, metabolism and virus propagation
V. Lohr et al.
VACCINE (2009)
Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK
Philip D. Minor et al.
VACCINE (2009)
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
Rebecca J. Cox et al.
VACCINE (2009)
Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
M. Keith Howard et al.
BIOLOGICAL CHEMISTRY (2008)
Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells
Kiyoto Nishiyama et al.
BIOLOGICALS (2008)
Establishment of higher passage PER.C6 cells for adenovirus manufacture
Marina Berdichevsky et al.
BIOTECHNOLOGY PROGRESS (2008)
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials)
Larisa Rudenko et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Christopher S. Ambrose et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells
Ding Yuan Oh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit
Birgit G. Bradel-Tretheway et al.
JOURNAL OF GENERAL VIROLOGY (2008)
H5N1 Avian Influenza Virus Induces Apoptotic Cell Death in Mammalian Airway Epithelial Cells
Tomo Daidoji et al.
JOURNAL OF VIROLOGY (2008)
Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells
Shin Murakami et al.
JOURNAL OF VIROLOGY (2008)
The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine
G. Gabriel et al.
VACCINE (2008)
A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines
Jens-Peter Gregersen
VACCINE (2008)
A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine
Jens-Peter Gregersen
VACCINE (2008)
Timely production of A/Fujian-like influenza vaccine matching the 2003-2004 epidemic strain may have been possible using Madin-Darby canine kidney cells
Keiichi Makizumi et al.
VACCINE (2008)
Canine MDCK cell lines are refractory to infection with human and mouse prions
Magdalini Polymenidou et al.
VACCINE (2008)
High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases
Kristen A. Smith et al.
VACCINE (2008)
Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines
Alan Yung-Chih Hu et al.
VACCINE (2008)
Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus
Mayo Ueda et al.
VIRUS RESEARCH (2008)
Establishment of canine RNA polymerase I-driven reverse genetics for influenza a virus: Its application for H5N1 vaccine production
Shin Murakami et al.
JOURNAL OF VIROLOGY (2008)
Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells
Zhaoti Wang et al.
VIROLOGY JOURNAL (2007)
An adenovirus vector-mediated reverse genetics system for influenza A virus generation
Makoto Ozawa et al.
JOURNAL OF VIROLOGY (2007)
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
Otfried Kistner et al.
VACCINE (2007)
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions
Samia Rourou et al.
VACCINE (2007)
Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses
Lars Opitz et al.
VACCINE (2007)
Unraveling trafficking of the kidney anion exchanger 1 in polarized MDCK epithelial cells
Emmanuelle Cordat
BIOCHEMISTRY AND CELL BIOLOGY (2006)
Strategies for developing vaccines against H5N1 influenza A viruses
Taisuke Horimoto et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media
Y. Genzel et al.
VACCINE (2006)
Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture
Y Genzel et al.
VACCINE (2006)
Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor
K Trabelsi et al.
JOURNAL OF BIOTECHNOLOGY (2006)
Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
C Nicolson et al.
VACCINE (2005)
The growth of attenuated influenza vaccine donor strains in continuous cell lines
JM Audsley et al.
JOURNAL OF VIROLOGICAL METHODS (2005)
Comparative study of influenza virus replication in Vero and MDCK cell lines
R Youil et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture
Y Genzel et al.
VACCINE (2004)
Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants
T Palker et al.
VIRUS RESEARCH (2004)
Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium
S Quesney et al.
CYTOTECHNOLOGY (2003)
Metabolic active-high density VERO cell cultures on microcarriers following apoptosis prevention by galactose/glutamine feeding
RZ Mendonça et al.
JOURNAL OF BIOTECHNOLOGY (2002)
Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children
SA Halperin et al.
VACCINE (2002)
Characterization of a porcine lung epithelial cell line suitable for influenza virus studies
SH Seo et al.
JOURNAL OF VIROLOGY (2001)
Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains
JA Tree et al.
VACCINE (2001)
The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines
MG Pau et al.
VACCINE (2001)
Hydrodynamic shear forces increase Japanese encephalitis virus production from microcarrier-grown Vero cells
SC Wu et al.
BIOPROCESS ENGINEERING (2000)
Share Paper
